Detail
LncRNA Name | LOC554202 |
Synonyms | MIR31HG, hsa-lnc-31, LncHIFCAR, LOC554202 |
Region | GRCh38_9:21455642-21559669 Sequence |
Ensembl | ENSG00000171889 |
RefSeq | NR_027054 |
Circulating | ✘ |
Drug-resisitant | ✘ |
Prognostic | ✘ |
MiRNA | ✔ |
Variant | ✘ |
TF | ✘ |
Methylation | ✔ |
Cancer Name | breast cancer |
ICD-0-3 | C50 |
Methods | qPCR etc. |
Sample | cell line (MCF10A) |
Expression Pattern | down-regulated |
Function Description | Both miR-31 and the host gene LOC554202 are down-regulated in the TNBC cell lines of basal subtype and over-expressed in the luminal counterparts. Treatment of the TNBC cell lines with either a de-methylating agent alone or in combination with a de-acetylating agent resulted in a significant increase of both miR-31 and its host gene, suggesting an epigenetic mechanism for the silencing of these two genes by promoter hypermethylation. Finally, both methylation-specific PCR and sequencing of bisulfite-converted DNA demonstrated that the LOC554202 promoter-associated CpG island is heavily methylated in the TNBC cell lines and hypomethylated in the luminal subtypes. |
Pubmed ID | 22289355 |
Year | 2012 |
Title | miR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer. |
External Links |
Links for LOC554202 | GenBank HGNC lncrnadb Noncode |
Links for breast cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.